Form 4 for ASBP Aspire Biopharma Holdings, Inc.
Accepted 2023-08-22 00:00:00 ET · period of report 2023-08-18 · accession 0001104659-23-094299 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-22 | 2023-08-18 | ASBP | PowerUp Sponsor LLC | 10% | S - Sale | — | -4.32M | 2.87M | -60% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares, par value $0.0001 | 2023-08-18 | S | D | 4,317,500 | — | 2,870,000 | D | — | — | (F1) On August 18, 2023, the Reporting Person sold (i) 4,317,500 Class A ordinary shares, par value $0.0001, of PowerUp Acquisition Corp. (the "Issuer") and (ii) 6,834,333 private placement warrants of the Issuer for an aggregate purchase price of $1.00. |